A new article in the peer-reviewed journal Human Gene Therapy describes the consensus reached by invited experts who participated in a meeting to evaluate the potential carcinogenicity of gene therapies.
Aurinia will explore possible sale, following push by shareholder
Aurinia Pharmaceuticals said it will start exploring strategic alternatives, including a potential sale. The announcement follows calls by one of its major shareholders, MKT Capital.